ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SNG Synairgen Plc

4.675
0.00 (0.00%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.675 4.36 4.99 - 60,335 08:00:27
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.53 9.41M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.68p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.41 million. Synairgen has a price to earnings ratio (PE ratio) of -0.53.

Synairgen Share Discussion Threads

Showing 1701 to 1725 of 99175 messages
Chat Pages: Latest  79  78  77  76  75  74  73  72  71  70  69  68  Older
DateSubjectAuthorDiscuss
31/3/2020
10:34
I've joined the club with 5.7k for a medium term hold.
dovey21
31/3/2020
10:31
A smaller British firm called Synairgen – which was previously a partner of AstraZeneca – is this week starting human trials to test if its existing lung treatment will help patients who have contracted Covid-19. HTTPS://www.dailymail.co.uk/money/markets/article-8138573/Drugs-giant-AstraZeneca-talks-governments-cure-virus.html
tidy 2
31/3/2020
10:30
Everready

I know you only joined Advfn five days ago and this is your first post but reading the announcement today will help.

_____

Two Phase II clinical trials in asthma showed that inhaled SNG001 treatment activated antiviral pathways in the lung along with improving lung function in patients with a respiratory viral infection.

We have also shown that treatment with inhaled SNG001 reduced lung viral load and lung pathology in an in vivo swine flu driven model of viral pneumonia.

At the time of the MERS-CoV outbreak in 2013, Synairgen collaborated with the National Institutes of Health (NIH) in the US to show that SNG001 could protect against MERS-CoV infection of lung cells in vitro.

jev1
31/3/2020
10:29
If anyone here has an LSE account can someone point out to Degsy this article:




Yes there are four drugs being tested by the WHO - all with a interferon-beta. I know of only one which is on the list of the WHO that can be administered orally.

This is bigger than the NHS IMO.

talk2dubya
31/3/2020
10:27
Brilliant:))
bmnsa
31/3/2020
10:26
A trial result in viral infections in COPD was due imminently but that trial has been suspended so that they can amend the protocol to include Covid 19 patients. The drug has been in lots of patients over the last few years so we know safety is not an issue. So assuming that gets up and running shortly it will run concomitantly with the 100 patient Covid 19 trial which has just started.
nobbygnome
31/3/2020
10:23
Have their been very favourable results recently on this drug?
everready1
31/3/2020
10:13
Yes they did it with the test straight through under special licence
bobaxe1
31/3/2020
10:11
Southampton scientists renew strategic collaboration with AstraZenecaHTTPS://www.uhs.nhs.uk/ClinicalResearchinSouthampton/Research/Facilities/NIHR-Southampton-Biomedical-Research-Centre/News-and-updates/Articles/Southampton-scientists-renew-strategic-collaboration-with-AstraZeneca.aspx
tidy 2
31/3/2020
10:08
>> euclid

Just imagine if the result is positive in this trial. Are the regulators just going to say fine, go away and do a phase III trial which takes another 6 months by which time the first major wave will be over. The pressure will be massive to conditionally approve the drug for use straight away. I suspect the US would also grant a EUA and it would be sold there as well. I am as certain as I can be that another trial will not be required in these extraordinary times.

nobbygnome
31/3/2020
10:02
When are results likely from the trials?
nmulm
31/3/2020
10:02
Hazl

They'll know within days if it's having the desired effect, not just from patient response but also whether the Interferon levels in the lung have increased to defend against the virus.

jev1
31/3/2020
09:59
I would assume that the manufacture of the SNG001 is now well underway, as a time delay from approval to first supplies wouldn’t be a good move. I wonder where the manufacture is taking place??
makendon
31/3/2020
09:58
We have a lot to look forward to....is an under statement!
If people seem visibly better by the treatment then I think word will get out one way or another.
It is as ever a waiting game.


talk2dubya


If anyone 1636 I hope that wasn't directed at me? I had no time to read posts last night and I thought tidy2's comment was very interesting.

hazl
31/3/2020
09:56
I just sold a few at 69 to bank a profit - I may buy them back plus a few if the price drops this pm.

When I see folk ramping another stock, it normally makes me angry - so feel free to feel angry......

I humbly suggest you research RMD (NYSE) they are the largest manufacturer of CPAP machines in the world and they also manufacture non-invasive ventilators.

They are a huge US company and their machines are cloud based to allow remote monitoring - and they pay a dividend! You will confirm all this when you do your own research.

They are so big that a few individuals on a UK BB will have no impact whatsoever on the share price (do they ever!)

SNG has been good to me and so I share my limited knowledge with you.

Regards

toffeeman
31/3/2020
09:54
Do a bit of recent reading on this trial. On success it will be rolled out for immediate use worldwide.
tidy 2
31/3/2020
09:51
Euclid

All protocol 'norms' are out of the window with COV19, understandably.

MHRA and HRA have already made statements to this effect.

It's happening in the USA too.

jev1
31/3/2020
09:48
Who knows euclid
Desperate times rules will be adjusted to facilitate use if it works IMO

d1nga
31/3/2020
09:48
how can this be fast tracked if it still has to go through a phase 3 trial?
euclid5
31/3/2020
09:38
Fast tracked for immediate use on success.
tidy 2
31/3/2020
09:38
Tidy

Spot on.

WHO wouldn't have selected it as one of the four possible solutions with the most merit and potential to combat COV19 if they didn't have positive data.

Selected from hundreds globally. :o)

jev1
31/3/2020
09:37
They would still need to work on a phase III trial - or would they not?
euclid5
31/3/2020
09:35
Treatment only Vaccines won't workVaccines won't work': US virologist breaks down COVID-19, how to curb s...Treatment only youtu.be/LVBc7-Te_yASNG001 Could be the only effective treatment.
tidy 2
31/3/2020
09:29
Reading between the lines of course. If it hadnt produced any positive results it would be cast aside and times like this have allowed them to reveal to the powers that be what Data they already have for SNG001
tidy 2
31/3/2020
09:26
Agree. Ive posted previously that independent data from the ongoing trials must have shown positive data for those trials to be halted in favour on COVID19 trials seeing that WHO picked SNG001 as one of the 4 drugs they narrowed down from the 100s that came forward
tidy 2
Chat Pages: Latest  79  78  77  76  75  74  73  72  71  70  69  68  Older

Your Recent History

Delayed Upgrade Clock